GeneBio Systems
Recombinant Human Urokinase/uPA protein (His tag)
Recombinant Human Urokinase/uPA protein (His tag)
SKU:PDMH100427
Couldn't load pickup availability
Size:100μg
Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping:This product is provided as lyophilized powder which is shipped with ice packs.
Exp date:12 months
Category ID_II:Recombinant Proteins
Category ID_III:Others
Abbreviation:Urokinase;uPA
Target Synonym:ATF;BDPLT5;PLAU;QPD;U-Plasminogen Activator;UPA;URK;Urokinase-Type Plasminogen Activator;u-PA;uPA
Research Areas:Cardiovascular;Neuroscience;Cancer;metabolism
Conjugation:
Target Species:Human
Expression Host:HEK293 Cells
Application:
Fusion tag:C-His
UNIProt ID:P00749
Accession:P00749
Background:Recombinant Human Urokinase-Type Plasminogen Activator is a serine protease, which specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. Urokinase-Type Plasminogen Activator is a potent marker of invasion and metastasis in many human cancers associated with breast, colon, stomach, bladder, brain, ovary and endometrium. Human Urokinase-Type Plasminogen Activator is initially synthesized as 431 amino acid precursor with a N-terminal signal peptide residues. The single chain molecule is processed into a disulfide-linked two-chain molecule. There exists two forms A chain, the long A chain contains an EGF-like domain that is responsible for binding of the uPA receptor. The B chain corresponds to the catalytic domain.
Concentration:
Activity:Not validated for activity
Sequence:Met1-Leu431
Purity: > 95% as determined by reducing SDS-PAGE.
Formulation:Lyophilized from sterile PBS, pH 7.4.
Normally 5%-8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.
Endotoxin:< 1.0 EU/mg of the protein as determined by the LAL method.
Calculated MW:47.3 kDa
ObservedMW:45 kDa
